These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 7491831

  • 1. [Transdermal and oral hormone substitution with estrogens: a comparison].
    Schindler AE.
    Zentralbl Gynakol; 1995; 117(10):504-7. PubMed ID: 7491831
    [Abstract] [Full Text] [Related]

  • 2. Comparative pharmacokinetics of oestradiol, oestrone, oestrone sulfate and "conjugated oestrogens" after oral administration.
    Schindler AE, Bolt HM, Zwirner M, Hochlehnert G, Göser R.
    Arzneimittelforschung; 1982; 32(7):787-91. PubMed ID: 6289846
    [Abstract] [Full Text] [Related]

  • 3. [Oral or transdermal estrogen substitution therapy in climacteric?].
    Runnebaum B, Salbach B, von Holst T.
    Geburtshilfe Frauenheilkd; 1994 Mar; 54(3):119-30. PubMed ID: 8188009
    [Abstract] [Full Text] [Related]

  • 4. [Clinical effectiveness of a new matrix plaster: an overview].
    Schindler AE, Schindler EM.
    Zentralbl Gynakol; 1995 Mar; 117(10):508-9. PubMed ID: 7491832
    [No Abstract] [Full Text] [Related]

  • 5. Biologic effects of transdermal estradiol.
    Chetkowski RJ, Meldrum DR, Steingold KA, Randle D, Lu JK, Eggena P, Hershman JM, Alkjaersig NK, Fletcher AP, Judd HL.
    N Engl J Med; 1986 Jun 19; 314(25):1615-20. PubMed ID: 3012339
    [Abstract] [Full Text] [Related]

  • 6. [Comparison of transdermal with oral hormone substitution: a multicenter study with a new matrix patch].
    Sajtos B, Herold J, Winkler UH, Schindler AE.
    Zentralbl Gynakol; 1995 Jun 19; 117(10):524-30. PubMed ID: 7491835
    [Abstract] [Full Text] [Related]

  • 7. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S, Zochowska E, Safranow K, Sieja K, Stanosz M.
    Metabolism; 2009 Jan 19; 58(1):1-7. PubMed ID: 19059524
    [Abstract] [Full Text] [Related]

  • 8. [Effect of hormone substitution therapy on AT III in women in the climacteric].
    Enzelsberger H, Heytmanek H, Kurz C, Metka M.
    Zentralbl Gynakol; 1991 Jan 19; 113(11):639-44. PubMed ID: 1656654
    [Abstract] [Full Text] [Related]

  • 9. Single-dose pharmacokinetics of sublingual versus oral administration of micronized 17 beta-estradiol.
    Price TM, Blauer KL, Hansen M, Stanczyk F, Lobo R, Bates GW.
    Obstet Gynecol; 1997 Mar 19; 89(3):340-5. PubMed ID: 9052581
    [Abstract] [Full Text] [Related]

  • 10. Oral but not transdermal estrogen replacement therapy changes the composition of plasma lipoproteins.
    Vrablik M, Fait T, Kovar J, Poledne R, Ceska R.
    Metabolism; 2008 Aug 19; 57(8):1088-92. PubMed ID: 18640386
    [Abstract] [Full Text] [Related]

  • 11. Comparison of continuation of postmenopausal hormone replacement therapy: transdermal versus oral estrogen.
    Ettinger B, Pressman A, Bradley C.
    Menopause; 1998 Aug 19; 5(3):152-6. PubMed ID: 9774760
    [Abstract] [Full Text] [Related]

  • 12. The effect of transdermal and vaginal estrogen therapy on markers of postmenopausal estrogen status.
    Gupta P, Ozel B, Stanczyk FZ, Felix JC, Mishell DR.
    Menopause; 2008 Aug 19; 15(1):94-7. PubMed ID: 17882008
    [Abstract] [Full Text] [Related]

  • 13. Alternatives to oral estrogen replacement. Transdermal patches, percutaneous gels, vaginal creams and rings, implants, other methods of delivery.
    Baker VL.
    Obstet Gynecol Clin North Am; 1994 Jun 19; 21(2):271-97. PubMed ID: 7936545
    [Abstract] [Full Text] [Related]

  • 14. [Estrogen replacement in postmenopause, blood coagulation and fibrinolysis: comparison of a new kind of transdermal estradiol treatment with oral therapy with conjugated estrogens].
    Winkler UH, Krämer R, Kwee B, Schindler AE.
    Zentralbl Gynakol; 1995 Jun 19; 117(10):540-8. PubMed ID: 7491837
    [Abstract] [Full Text] [Related]

  • 15. Effects of transdermal and oral estrogen replacement on lipids and glucose metabolism in postmenopausal women with type 2 diabetes mellitus.
    Araújo DA, Farias ML, Andrade AT.
    Climacteric; 2002 Sep 19; 5(3):286-92. PubMed ID: 12419087
    [Abstract] [Full Text] [Related]

  • 16. Modulation by progestogens of the effects of oestrogen on hepatic endocrine function in postmenopausal women.
    Nugent AG, Leung KC, Sullivan D, Reutens AT, Ho KK.
    Clin Endocrinol (Oxf); 2003 Dec 19; 59(6):690-8. PubMed ID: 14974909
    [Abstract] [Full Text] [Related]

  • 17. Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women.
    Vehkavaara S, Silveira A, Hakala-Ala-Pietilä T, Virkamäki A, Hovatta O, Hamsten A, Taskinen MR, Yki-Järvinen H.
    Thromb Haemost; 2001 Apr 19; 85(4):619-25. PubMed ID: 11341495
    [Abstract] [Full Text] [Related]

  • 18. The effects of transdermal estradiol and oral conjugated estrogens on haemostasis variables.
    Kroon UB, Silfverstolpe G, Tengborn L.
    Thromb Haemost; 1994 Apr 19; 71(4):420-3. PubMed ID: 8052956
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics and pharmacodynamics of transdermal dosage forms of 17 beta-estradiol: comparison with conventional oral estrogens used for hormone replacement.
    Powers MS, Schenkel L, Darley PE, Good WR, Balestra JC, Place VA.
    Am J Obstet Gynecol; 1985 Aug 15; 152(8):1099-106. PubMed ID: 2992279
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics of estradiol and of estrone during application of a new 7-day estradiol transdermal patch with active matrix.
    Setnikar I, Rovati LC, Vens-Cappell B, Hilgenstock C.
    Arzneimittelforschung; 1998 Mar 15; 48(3):275-85. PubMed ID: 9553686
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.